Axim Biotechnologies, Inc. (AXIM): EPS (Diluted)

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2021-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$0.04
Year ended 2023-12-31
$0.122019-12-31: -$0.102020-12-31: -$0.062021-12-31: $0.122022-12-31: -$0.042023-12-31: -$0.04-$0.04
2019-12-31 EPS (Diluted) (USD per share) 2023-12-31
Period endedEPS (Diluted)Change YoYSource filing
2023-12-31-$0.04n/m2024-04-16, From 2023-01-01
2022-12-31-$0.04n/c2024-04-16, From 2022-01-01
2021-12-31$0.12n/c2023-04-17, From 2021-01-01
2020-12-31-$0.06n/m2022-04-19, From 2020-01-01
2019-12-31-$0.10n/a2021-04-26, From 2019-01-01